Skip to content
Screener

Enanta Pharmaceuticals ENTA Q1 2026 earnings

Reported May 11, 2026 · Before market open

Revenue$17.2MBeat by $131.7K
EPS-$0.45Beat by $0.01
Revenue estimate$17.0M
EPS estimate-$0.46

Next report

Nov 16, 2026 (in 2 months)
Revenue estimate$15.7M
EPS estimate-$0.77

FAQ

When did Enanta Pharmaceuticals report Q1 2026 earnings?
Enanta Pharmaceuticals (ENTA) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Enanta Pharmaceuticals's Q1 2026 revenue and EPS?
Enanta Pharmaceuticals reported revenue of $17.2M and eps of $-0.45 for Q1 2026.
Did Enanta Pharmaceuticals beat estimates in Q1 2026?
Revenue beat the consensus estimate of $17.0M by $131.7K. EPS beat the consensus estimate of $-0.46 by $0.01.
How did Enanta Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.0% from $14.9M a year earlier and eps grew 57.5% from $-1.06.
Where can I find Enanta Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-216735) and the 10-Q periodic report (0001193125-26-220572) directly on SEC EDGAR. The filing index links above go to sec.gov.